--%>

Metabolic dysfunction-associated steatotic liver disease


Question:

How do you write HPI for The patient's recent laboratory results suggest several concurrent health concerns that require a coordinated approach for further evaluation and management. Lab results highlighted metabolic dysfunction-associated steatotic liver disease (MASLD), potential prediabetes/early type 2 diabetes, macrocytosis with secondary erythrocytosis, and elevated PSA levels. The patient's laboratory tests also display elevated liver enzymes (AST 56 U/L, ALT 66 U/L), elevated fasting glucose (117 mg/dL), macrocytosis (MCV 106.8 fL), elevated hemoglobin (Hgb 16.9 g/dL, Hct 52.0%), elevated PSA (5.78 ng/mL), elevated magnesium (2.4 mg/dL), and high-normal potassium (5.2 mmol/L). For Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Elevated Liver Enzymes: AST: 56 U/L (normal range: up to 40 U/L), ALT: 66 U/L (normal range: up to 40 U/L). Recommend hepatology consultation for further evaluation and management. For the Prediabetes/Early Type 2 Diabetes: Elevated Fasting Glucose: 117 mg/dL (normal range: 70-99 mg/dL). Suggest dietary modifications and potential endocrinology referral. For the Macrocytosis with Secondary Erythrocytosis: MCV: 106.8 fL (normal range: 80-100 fL), Hemoglobin/Hematocrit: Hgb: 16.9 g/dL (normal range: 13.5-17.5 g/dL for men), Hct: 52.0% (normal range: 40-50% for men). Recommend review of potential causes (vitamin deficiency, chronic hypoxia) and follow-up testing. For the Elevated PSA: PSA: 5.78 ng/mL. Need Assignment Help?

 

Request for Solution File

Ask an Expert for Answer!!
Other Subject: Metabolic dysfunction-associated steatotic liver disease
Reference No:- TGS03502620

Expected delivery within 24 Hours